Location History:
- Osaka-fu, JP (2000 - 2005)
- Minoo, JP (2003 - 2005)
- Kyoto-fu, JP (2009)
- Osaka, JP (2006 - 2013)
- Kyoto, JP (2016 - 2018)
- Suita, JP (1993 - 2023)
Company Filing History:
10 out of 19 
9 out of 229 
5 out of 820 
Years Active: 1993-2023
Title: Shigekazu Nagata: Innovator in Pharmacological Research
Introduction
Shigekazu Nagata is an accomplished inventor based in Suita, Japan, known for his substantial contributions to pharmacological research. With a total of 23 patents to his name, Nagata has focused on developing innovative methods that enhance our understanding of cellular processes and potential therapeutic applications.
Latest Patents
Among Shigekazu Nagata's latest innovations is a patent that details a method for screening inhibitors of ATP11C or CDC50A. This invention involves determining the exposure of phosphatidylserine on the cell surface, the engulfment of cells by macrophages, or the cleavage of ATP11C by caspase. Furthermore, the invention also encompasses a method for inducing the engulfment of cells by macrophages through the inhibition of ATP11C or CDC50A. This groundbreaking work holds the potential to advance research in cellular clearance and therapeutic interventions.
Career Highlights
Throughout his career, Nagata has worked with reputable organizations, such as the Osaka Bioscience Institute and Mochida Pharmaceutical Co., Ltd. His experiences within these institutions have enabled him to hone his skills and deepen his knowledge in the field, leading to the inception of significant innovations in drug discovery and development.
Collaborations
In the course of his professional journey, Shigekazu Nagata has collaborated with esteemed colleagues, including Norio Nakamura and Takashi Suda. These partnerships have fostered an environment of creativity and shared expertise, driving forward the research and development of his remarkable inventions.
Conclusion
Shigekazu Nagata stands as a prominent figure in the realm of pharmacological innovation, exemplified by his impressive portfolio of patents and collaborative efforts. His work not only advances the scientific community's understanding of cellular mechanisms but also paves the way for future therapeutic developments. As he continues to explore new frontiers in research, his contributions will undoubtedly leave a lasting impact on the field.